326 related articles for article (PubMed ID: 12066168)
1. Cardiovascular biology: a cholesterol tether.
Staels B
Nature; 2002 Jun; 417(6890):699-701. PubMed ID: 12066168
[No Abstract] [Full Text] [Related]
2. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of remnant-lipoprotein].
Nakamura Y; Miida T
Nihon Rinsho; 2004 Dec; 62 Suppl 12():22-5. PubMed ID: 15658253
[No Abstract] [Full Text] [Related]
4. Apolipoprotein B gene: plasma cholesterol and atherosclerosis.
Scott J; Pease RJ; Powell LM; Wallis SC; McCarthy BJ; Mahley RW; Levy-Wilson B; Knott TJ
Biochem Soc Symp; 1987; 53():155-63. PubMed ID: 3332766
[No Abstract] [Full Text] [Related]
5. [Major aspects of pathogenesis in atherosclerosis: current status and perspectives].
Titov VN
Ter Arkh; 2001; 73(12):78-82. PubMed ID: 11858118
[No Abstract] [Full Text] [Related]
6. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
7. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
Yanni AE; Perrea DN; Yatzidis HA
Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
[TBL] [Abstract][Full Text] [Related]
8. [Apolipoprotein B100 and LDL receptors: genetic and metabolic aspects].
Chapman MJ
Journ Annu Diabetol Hotel Dieu; 1991; ():35-7. PubMed ID: 1653378
[No Abstract] [Full Text] [Related]
9. Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.
Fredrikson GN; Björkbacka H; Söderberg I; Ljungcrantz I; Nilsson J
J Intern Med; 2008 Dec; 264(6):563-70. PubMed ID: 18783480
[TBL] [Abstract][Full Text] [Related]
10. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
11. [Overview: Atherogenic lipoproteins and their clinical significance].
Shirai K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():5-9. PubMed ID: 15658249
[No Abstract] [Full Text] [Related]
12. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.
Olofsson SO; Borèn J
J Intern Med; 2005 Nov; 258(5):395-410. PubMed ID: 16238675
[TBL] [Abstract][Full Text] [Related]
13. [The use of apolipoprotein B in clinical practice to determine the risk for atherosclerosis].
Cabezas Castro M; Liem A
Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1445-8. PubMed ID: 12908345
[TBL] [Abstract][Full Text] [Related]
14. [Lipoproteins and their metabolism].
Rywik S; Broda G
Kardiol Pol; 1992; 36(2):110-4. PubMed ID: 1583826
[No Abstract] [Full Text] [Related]
15. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.
Flood C; Gustafsson M; Pitas RE; Arnaboldi L; Walzem RL; Borén J
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):564-70. PubMed ID: 14726411
[TBL] [Abstract][Full Text] [Related]
17. Effect of miscleron on serum lipid parameters in atherosclerosis induced by cholesterol.
Virág S; Dénes R; Pozsonyi T; Tury K
Ther Hung; 1971; 19(4):148-9. PubMed ID: 4336261
[No Abstract] [Full Text] [Related]
18. [Regulation of cholesterol metabolism and the development of atherosclerosis].
Pitsin D
Vutr Boles; 1987; 26(5):16-23. PubMed ID: 2829445
[No Abstract] [Full Text] [Related]
19. Daily melatonin supplementation in mice increases atherosclerosis in proximal aorta.
Tailleux A; Torpier G; Bonnefont-Rousselot D; Lestavel S; Lemdani M; Caudeville B; Furman C; Foricher R; Gardes-Albert M; Lesieur D; Rolando C; Teissier E; Fruchart JC; Clavey V; Fievet C; Duriez P
Biochem Biophys Res Commun; 2002 May; 293(3):1114-23. PubMed ID: 12051775
[TBL] [Abstract][Full Text] [Related]
20. Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice.
Lewis KE; Kirk EA; McDonald TO; Wang S; Wight TN; O'Brien KD; Chait A
Circulation; 2004 Aug; 110(5):540-5. PubMed ID: 15277327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
